Cancer - Press Review (May 25, 2013) – Revue de presse (25 mai 2013)

[SMW]

Cancer – Press Review – Revue de Presse

Every week on http://marclacroixcancerblog.blogspot.com
Chaque semaine sur http://marclacroixcancerblog.blogspot.com




Press Review (May 25, 2013) – Revue de presse (25 mai 2013)



Older Men Should Pass on Getting Prostate Cancer Treatment
The advice to detect and treat cancers at the first opportunity may
not apply to older men with prostate tumors, according to the latest
study
By Alexandra Sifferlin. In TIME
http://healthland.time.com/2013/05/23/older-men-should-pass-on-getting-prostate-cancer-treatment/

The Way We Think about Cancer Must Evolve
Right now, as you read these words, your life is in danger. Somewhere
within the vast self-contained micro-universe known as you, in one and
possibly more of your trillions of cells, something is going wrong. A
vital protein, perhaps, is being altered or destroyed as one cell
divides to create another. The mutated cell, an incorrect version of
its former self, will continue to multiply, compounding and extending
its grotesque influence as an intruder and usurper, bent on its own
self- preservation at your expense. It has become cancer.
By Mark Wolverton. In Wired
http://www.wired.com/wiredscience/2013/05/al_argcancer/

American Cancer Society Celebrates 100 Years of Progress
One million cancer deaths avoided since 1990s, group says.
In U.S. News & World Report
http://health.usnews.com/health-news/news/articles/2013/05/22/american-cancer-society-celebrates-100-years-of-progress

Cancer: Drug for an 'undruggable' protein
Scientists have long aimed to develop drugs against the cancer-
associated protein KRAS, but without success. An approach that targets
the oncoprotein's cellular localization reignites lost enthusiasm.
By Nicole M. Baker & Channing J. Der. In Nature
http://www.nature.com/nature/journal/vaop/ncurrent/full/nature12248.html

Promising New Approach to Treatment of Lung Cancer
Researchers have developed a new drug delivery system that allows
inhalation of chemotherapeutic drugs to help treat lung cancer, and in
laboratory and animal tests it appears to reduce the systemic damage
done to other organs while significantly improving the treatment of
lung tumors.
In Science Daily
http://www.sciencedaily.com/releases/2013/05/130522131212.htm


Cancer : optimisme à géométrie variable
Le regard sur le cancer profondément évolué ces dernières décennies à
la faveur des progrès de la médecine. Désormais, ce n’est plus
seulement la fatalité et le pessimisme qui dominent lorsqu’on évoque
ces pathologies. L’enquête d’opinion PACE (Patient Acces and Cancer
Care Excellence) menée sous l’égide des laboratoires Lilly dans six
pays (Allemagne, Italie, Royaume-Uni, Japon, Etats-Unis et France)
auprès, dans chaque état, d’une centaine de patients, d'une centaine
de professionnels de santé et de cinq cent personnes dans la
population générale, confirme cette évolution.
Par Léa Crébat. Dans JIM
http://www.jim.fr/en_direct/pro_societe/e-docs/00/02/1F/59/document_actu_pro.phtml

Métastases osseuses du cancer de la prostate : la FDA donne son accord
à Xofigo
L'agent, le radium-223 dichloride (connu sous le nom d'alpharadin), a
reçu une autorisation de mise sur le marché (AMM) de la Food and Drug
Administration (FDA) le 15 mai. Il sera commercialisé par les
laboratoires Bayer sous le nom de Xofigo® dans le traitement du cancer
de la prostate avec métastase(s) osseuse(s) uniquement, chez les
hommes ayant préalablement bénéficié d'une autre thérapie visant à
influer sur le taux de testostérone
Par Zosia Chustecka, Aude Lecrubier. Dans Medscape
http://www.medscape.fr/oncologie/articles/1540973/







Cancer Blog – Marc Lacroix – Le Blogue du Cancer
http://marclacroixcancerblog.blogspot.com













Marc Lacroix-Corman – InTextoResearch – Baelen (05/2013)